Androgen receptors in early and castration resistant prostate cancer: friend or foe?
نویسندگان
چکیده
Address for correspondence: Dr Marilena Kampa, University of Crete, School of Medicine, Laboratory of Experimental Endocrinology, P.O. Box 2208, Heraklion, 71110, Crete, Greece, Tel.: +3
منابع مشابه
Friend or foe: the bifunctional role of steroid hormones in prostate cancer.
Nearly all men with advanced prostate cancer will receive androgen deprivation therapy (ADT) as primary treatment. Fortunately, the majority of men treated with ADT will experience objective disease response; however, these men are also likely to experience the adverse effects of ADT, such as fatigue, sexual dysfunction, decreased bone mineral density, and increased risk of cardiovascular morbi...
متن کاملIs DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?
The first advance in the history of studies on prostate cancer (PCa) and androgens was the development of treatment with castration and administration of estrogen by Charles B. Huggins, who won the Nobel Prize in Physiology and Medicine. Since then, and for 70 years, androgen deprivation therapy has been the standard therapy for advanced PCa and the center of studies on PCa. However, recent adv...
متن کاملSingle Orbital Metastasis in Castration-Resistant Prostate Cancer
Introduction: Orbital metastasis of prostate cancer (PC) is very rare and even more unique in castration-resistant PC (CRPC). In this scenario, choline positron emission tomography/computed tomography (choline PET/CT) is the gold-standard restaging method of choice available in our setting, and new anti-androgens treatments show improvement in overall survival. Case presentation: We report the...
متن کاملSingle Orbital Metastasis in Castration-Resistant Prostate Cancer
Introduction: Orbital metastasis of prostate cancer (PC) is very rare and even more unique in castration-resistant PC (CRPC). In this scenario, choline positron emission tomography/computed tomography (choline PET/CT) is the gold-standard restaging method of choice available in our setting, and new anti-androgens treatments show improvement in overall survival. Case presentation: We report the...
متن کاملGlucocorticoids and prostate cancer treatment: friend or foe?
Glucocorticoids have been used in the treatment of prostate cancer to slow disease progression, improve pain control and offset side effects of chemo- and hormonal therapy. However, they may also have the potential to drive prostate cancer growth via mutated androgen receptors or glucocorticoid receptors (GRs). In this review we examine historical and contemporary use of glucocorticoids in the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Hormones
دوره 12 2 شماره
صفحات -
تاریخ انتشار 2013